CMO's Cannot Produce SP2/0 Working Cell Bank: Cytovance® Identifies Problem And Successfully Produces WCB
Source: Cytovance Biologics

A client had purchased a Master Cell Bank that had been manufacturing in 1999. The client is able to grow cells successfully in the R&D laboratory. However when they transferred vials of MCB to a well-known CMO to manufacture a WCB the CMO failed several times to successfully manufacture a WCB. Continue reading to learn how Cytovance identified the problem and successfully produced WCB.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Cytovance Biologics
This website uses cookies to ensure you get the best experience on our website. Learn more